# Eupraxia Pharmaceuticals Inc.: Form SCHEDULE 13D/A, filed Sep 26, 2025

- Company: [Eupraxia Pharmaceuticals Inc.](/companies/eprx.md) (CIK 1581178)
- Form: SCHEDULE 13D/A
- Filed: 2025-09-26
- Accepted by EDGAR: Sep 27, 2025, 01:19 ET
- Period: not reported
- Accession: 0000899140-25-001145
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1581178/000089914025001145/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1581178/000089914025001145/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1581178/000089914025001145/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Sep 26, 2025.
Source: SEC EDGAR, the filing index for accession 0000899140-25-001145. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.